QA: Amicus Therapeutics INC in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001178879_2025_Amicus_Therapeutics_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001178879, Amicus Therapeutics INC

  xvar xval
0 AssetsCurrent 504,736,000
1 IntangibleAssetsNetIncludingGoodwill 214,995,000
2 PropertyPlantAndEquipmentNet 29,383,000
3 remainder_Assets 35,919,000
4 LiabilitiesCurrent 148,702,000
5 LiabilitiesNoncurrent 52,175,000
6 remainder_Liabilities 390,111,000
7 CostOfGoodsAndServicesSold 69,423,186
8 SellingGeneralAndAdministrativeExpense 405,995,695
9 ResearchAndDevelopmentExpense 86,129,978
10 remainder_Expenses 86,264,676
11 remainder_Revenues 588,137,370
12 remainder_NetIncome -10,706,743
13 remainder_ComprehensiveNetIncome 7,803,032
  yvar yval
0 Assets 785,033,000
1 Liabilities 590,988,000
2 Expenses 647,813,535
3 Revenues 588,137,370
4 StockholdersEquity 194,045,000
5 NetIncome -70,382,908
6 ComprehensiveNetIncome -66,481,392
7 BaseVar 1,315,240,840
8 EconomicCapitalRatiobeforeLimitedLiability 0.518
9 EconomicCapitalRatio 1.90

Edgar->Model Mapping

Feature Distribution

Change over Time